INVO Fertility, Inc. (IVF) vs Silo Pharma, Inc. (SILO)
A side-by-side comparison of INVO Fertility, Inc. and Silo Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IVF
INVO Fertility, Inc.
$0.80HealthcareDelayed quote: Oct 6, 2026, 2:11 PM EDT
SILO
Silo Pharma, Inc.
$1.45HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
Total return — IVF vs SILO
growth of $100 · dividends reinvested · last 6yIVF -100.0% (-85.5%/yr)SILO -99.4% (-57.8%/yr)SILO compounded faster over this window
Log scale — wide-divergence pair
IVF SILO
IVF vs SILO: by the numbers
- •SILO is the larger company ($2M vs $1M market cap).
- •Both run net losses; IVF's is the smaller (-70.18% vs -8269.53% net margin).
- •IVF grew revenue faster over the past five years (39.51% vs 0.29% CAGR).
Metrics side by side
Valuation
| Metric | IVF | SILO |
|---|---|---|
| P/S ratio | 0.19 | 30.26 |
| P/B ratio | 0.09 | 0.33 |
Profitability
| Metric | IVF | SILO |
|---|---|---|
| Gross margin | 33.34% | -1128.89% |
| Operating margin | -78.72% | -5936.95% |
| Net margin | -70.18% | -8269.53% |
| ROE | -32.05% | -91.52% |
| ROIC | -28.43% | -91.31% |
Growth (annualized)
| Metric | IVF | SILO |
|---|---|---|
| Revenue CAGR (5Y) | 39.51% | 0.29% |
| Total return CAGR (5Y) | -90.41% | -61.41% |
Frequently asked
- Which has grown faster, IVF or SILO?
- Over the past five years, IVF grew revenue faster — IVF at a 39.51% CAGR versus SILO at 0.29%.
- How have IVF and SILO total returns compared?
- Over the past 5 years, IVF delivered -90.41% and SILO delivered -61.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
INVO Fertility ROESilo Pharma ROEINVO Fertility operating marginSilo Pharma operating marginINVO Fertility revenue growthSilo Pharma revenue growthINVO Fertility free cash flowSilo Pharma free cash flow
INVO Fertility & Silo Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.